This Season’s Flu Shot Was Less Effective. What Older Adults Should Do Now

Short answer: yes, this season’s flu shot appears to have protected adults less well than in many recent years. But that is not the same as saying it failed.

For older adults, the practical message is straightforward: flu vaccination still matters, age 65 and older remains the highest-risk group for severe flu outcomes, and fast action matters if symptoms start. In a season with weaker vaccine protection, getting treated early becomes even more important.

The new CDC numbers in plain English

On March 12, 2026, the CDC published interim results from three U.S. vaccine-effectiveness networks. This was an observational analysis, not a seniors-only clinical trial. Researchers used a common “test-negative” design, comparing people who sought care for respiratory illness and tested positive for flu with similar patients who tested negative. The analysis included 142,494 people.

Among adults overall, the flu shot was estimated to reduce flu-related outpatient visits by 22% to 34% and flu-related hospitalization by 30%. Those numbers are lower than many people hope for, and lower than in several recent seasons. But they still show measurable protection, especially against severe illness that can lead to a hospital stay.

That distinction matters. A lower-effectiveness season is not the same as zero benefit. It means the shot helped less than usual, not that it was pointless.

Why this matters more for older adults

Age is the strongest risk factor here. CDC guidance for clinicians says risk rises as people get older, and adults 65 and older face the highest risk of flu hospitalization and death. That is why a disappointing vaccine season should matter most to seniors, their families, and caregivers.

Older adults also do not always get the “classic” flu picture. Fever, cough, sore throat, chills, body aches, and deep fatigue are common, but some people mainly notice weakness, loss of appetite, worsening of heart or lung disease, or sudden confusion. If you are older or caring for someone older, it is worth taking flu-like symptoms seriously even if they seem mild at first.

This is also a reminder that prevention is layered. Vaccination is still the foundation, but it works best alongside basic steps like avoiding close contact with sick people, improving indoor air when possible, washing hands, staying home when ill, and keeping chronic conditions well managed.

Vaccination rates add more context. National data show that flu vaccination among adults 65 and older was 67.1% in 2024, down from 70.5% in 2019. In other words, a weaker season does not make prevention less relevant. It makes clear, practical prevention more important.

Why CDC prefers certain flu shots for adults 65 and older

For people 65 and older, the CDC’s Advisory Committee on Immunization Practices says three flu vaccine types are preferred when available: high-dose inactivated vaccine, recombinant vaccine, and adjuvanted inactivated vaccine. If none of those is available at the time you are getting vaccinated, an age-appropriate standard flu shot should still be used rather than waiting and risking no protection at all.

The reasoning is practical. As people age, the immune system often responds less strongly to vaccination. These age-preferred vaccines are designed to improve the immune response or offer greater potential benefit in older adults. At the same time, experts do not say one of these three clearly beats the other two in every situation. Head-to-head comparisons are limited.

That is worth knowing for next season too. If you are 65 or older and you have a choice, ask specifically whether a high-dose, recombinant, or adjuvanted flu vaccine is available. If the answer is no, getting another age-appropriate flu shot is still better than staying unvaccinated.

What older adults should do now if symptoms begin

If you are 65 or older and you develop flu-like symptoms, do not wait several days to “see how it goes.” Call your clinician, urgent care, or telehealth service early and ask whether you should be tested and whether antiviral treatment makes sense.

CDC guidance says antiviral treatment works best when started as soon as possible, ideally within two days of symptom onset. But for people at higher risk of complications, including adults 65 and older, treatment may still be recommended even when that two-day window has passed.

This is an important point in a lower-effectiveness season: antivirals do not replace vaccination, but they add another layer of protection after symptoms begin. The goal is to lower the chance that an infection turns into pneumonia, dehydration, a hospital stay, or a dangerous flare of conditions like heart failure, COPD, asthma, or diabetes.

Call promptly if fever, cough, sore throat, body aches, or unusual weakness start.
Ask whether testing is needed and whether an antiviral such as oseltamivir is appropriate.
Seek urgent care right away for trouble breathing, chest pain, severe dehydration, blue lips, new confusion, or rapidly worsening symptoms.
If you live with frail relatives or have caregiving duties, let the medical team know. That can affect how quickly treatment and isolation advice are handled.

Why protection was weaker this season

The simplest explanation is that the main flu virus spreading this season was not a close match to the strain the vaccine had to target months earlier. CDC reported that most subtyped influenza A viruses this season were A(H3N2), and that the dominant subclade differed from the vaccine strain chosen before the season began.

That kind of strain drift is frustrating, but it is not unusual in flu. Vaccine strains have to be selected well before winter, and sometimes the viruses that actually take off later are somewhat different. Even then, vaccines can still provide partial protection, which is what the CDC’s interim data suggest happened this season.

What remains uncertain

There are still limits to what we can say. These are interim estimates, so they may change when final end-of-season data are published. The CDC report also was not designed as a head-to-head study of older adults alone, and like other observational vaccine-effectiveness studies, it can be affected by unmeasured differences between people who got vaccinated and those who did not.

That means readers should avoid two oversimplified takeaways: first, that the shot “didn’t work,” and second, that one difficult season proves flu vaccination is not worth it. Neither claim fits the evidence.

A more accurate conclusion is this: this was a harder flu season for the vaccine, especially for adults, but the vaccine still reduced medical visits and hospitalizations. For older adults, that reduced protection is still meaningful because the consequences of flu are more serious in this age group.

What this means for readers

If you are an older adult, or you care for one, do not let a weaker flu-shot season turn into resignation. The better response is practical:

Keep getting an annual flu shot.
If you are 65 or older, ask for a high-dose, recombinant, or adjuvanted vaccine when available.
If symptoms start, contact a clinician quickly about testing and antiviral treatment.
Use layered protection during active flu spread, especially if you have heart disease, lung disease, diabetes, kidney disease, or weakened immunity.

In other words, this season’s lesson is not that vaccination was useless. It is that older adults need both prevention and a fast treatment plan.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.